Wyden Continues Investigation Into Big Pharma Tax Practices
Following letter to AbbVie, Wyden requests information from Bristol Myers Squibb Washington, D.C. -- Senate Finance Committee Chair Ron Wyden, D-Ore., today continued his investiga…
Following letter to AbbVie, Wyden requests information from Bristol Myers Squibb Washington, D.C. -- Senate Finance Committee Chair Ron Wyden, D-Ore., today continued his investiga…